Friedman L. The NHLBI model: a 25 year history. Stat Med1993; 12: 425–431.
2.
Heart Special Project Committee. Organization, review and administration of cooperative studies: a report from the Heart Special Project Committee to the National Advisory Heart Council, May 1967. Control Clin Trials1988; 9: 137–148.
3.
George SL. A survey of monitoring practices in cancer clinical trials. Stat Med1993; 12: 435–450.
4.
Ellenberg SS, Myers MW, Blackwelder WC, Hoth DF. The use of external monitoring committees in clinical trials of the National Institute of Allergy and Infectious Diseases. Stat Med1993; 12: 461–467.
5.
Pater JL. The use of data monitoring committees in Canadian trial groups. Stat Med1993; 12: 505–508.
6.
Buyse M. Interim analyses, stopping rules and data monitoring in clinical trials in Europe. Stat Med1993; 12: 509–520.
7.
Geller NL, Stylianou M. Practical issues in data monitoring of clinical trials: summary of responses to a questionnaire at NIH. Stat Med1993; 12: 543–551.
8.
Parmar MK, Machin D. Monitoring clinical trials: experience of, and proposals under consideration by, the Cancer Therapy Committee of the British Medical Research Council. Stat Med1993; 12: 497–504.
9.
Hawkins BS. Data monitoring committees for multicenter clinical trials sponsored by the National Eye Institute. Control Clin Trials1991; 12: 424–437.
10.
US Food and Drug Administration. Guidance for Clinical Trial Sponsors on the Establishment and Operation of Clinical Trial Data Monitoring Committees. Rockville, MD: FDA. November 2001. http://www.fda.gov/cber/gdlns/clindatmon.htm. Last accessed 3 November 2003.
11.
Ellenberg SS, Fleming TR, DeMets, DL. Data monitoring committees in clinical trials: a practical perspective. Chichester: John Wiley, 2002.
12.
Sydes MR, Altman DG, Babiker AB, Parmar MKB, Spiegelhalter DJ, the DAMOCLES group. The reported use of data monitoring committees in the main published reports of randomised controlled trials: a crosssectional study. Clin Trials2004; 1, 48–59.
13.
Sydes MR, SpiegelhalterDJ, Altman DG, Babiker AB, Parmar MKB, the DAMOCLES group. Systematic qualitative review of the literature on data monitoring committees for randomised controlled trials. Clin Trials2004; 1, 60–79.
14.
Kiri A, Tonascia S, Meinert CL. The relationship between treatment effects monitoring in clinical trials and early stops. Clin Trials2004; 1, 40–47.
15.
Meinert C. Clinical trials and treatment effects monitoring. Control Clin Trials1998; 19: 515–522.